NOAA's newest research ship, the Reuben Lasker, departed San Diego this week on its first scientific mission, which includes surveying gray whales along the West Coast. The survey will also search the Gulf of Alaska for right whales, among the most rare and endangered whales on Earth. The expedition is a collaboration between the Southwest Fisheries Science Center in La Jolla, California, and Alaska Fisheries Science Center in Seattle.
PNNL named a lead laboratory for new DOE Pilot designed to give small clean energy firms more technology assistance from DOE labs.
In partnership with the Italian Society of Physiotherapy and the University of Applied Sciences and Arts of Southern Switzerland, BioMed Central has launched Archives of Physiotherapy. It is one of the few open-access journals specializing solely in the subject of physiotherapy. The article-processing charges will be covered on behalf of authors by both organizations for the first four years of publication.
Canadian researchers have launched the world's first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional chemotherapy and radiation, although it will take years to rigorously test through this trial and others.
Current climate models do not accurately account for humans' role in changing the environment, according to a UChicago-led team of international researchers embarking upon a project to help climate scientists better document land cover and use over the past 10,000 years.
The publication of scientific articles by Spanish university researchers has grown by 104.24 percent in the last decade, despite there being no significant increase in the number of professors during the same period. This data comes from the University Research, Development and Innovation annual report, recently published by the Observatorio IUNE, part of Alianza 4U, from the Universitat Autónoma and Universitat Pompeu Fabra in Barcelona and Universidad Autónoma and Universidad Carlos III in Madrid.
Florida Hospital Celebration Health recently became the 1,000th participating site in the American College of Cardiology's ACTION Registry-GWTG. This important milestone further expands the number of heart attack patients with access to improved care and outcomes through their hospital's participation in the registry.
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
The 2016 Physician Fee Schedule Proposed Rule includes codes recognizing Advance Care Planning -- an essential element of high-quality care that supports patients in aligning their future care with what is most important to them through ongoing conversations with their healthcare professionals.
The Johns Hopkins Drug Discovery program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.